Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
48.00    0.00 (0.00%)
Bid:
47.00
Ask:
49.00
Spread: 2.00 (4.255%)
Market Cap: £7.31m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

Total Voting Rights

31 Aug 2023 17:00

RNS Number : 9548K
Transense Technologies PLC
31 August 2023
 

Transense Technologies plc

 ("Transense" or the "Company")

 

Total voting rights

 

Transense Technologies plc, the developer of specialist sensor systems, announces that the issued share capital of the Company at the date of this announcement comprises 16,437,740 ordinary shares of 10 pence ("Ordinary Shares"). The Company holds 935,356 Ordinary Shares in treasury and therefore, the total number of voting rights in the Company is 15,502,384.

 

The figure of 15,502,384 should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Melvyn Segal (CFO)

Via Walbrook PR

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter / George Payne (Corporate Finance)

Tony Quirke/Jos Pinnington (Sales and Corporate Broking)

Tel: +44 (0)20 3328 5656

Walbrook PR

Tom Cooper / Nick Rome

Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com

Notes to Editors:

 

Transense is headquartered in Oxfordshire, UK and its shares are traded on AIM, a market operated by the London Stock Exchange (AIM: TRT). The Company develops and supplies advanced sensor technology and measurement solutions used by some of the world's leading companies to improve performance, efficiency and safety in demanding, mission critical applications. Transense currently operates through two active business segments:

 

· SAWsense - designs, supplies and licences advanced sensor solutions based on proven, patent protected Surface Acoustic Wave (SAW) technology to world leading companies in aerospace, electric motors and drives, industrial machinery (including robotics) and motor sport. Key customers include GE Aerospace, Parker Meggitt, McLaren Applied and several other confidential Tier One automotive and aerospace suppliers.

 

· Translogik - develops smart, connected commercial vehicle tyre inspection equipment to many of the world's leading tyre suppliers, fleet operators and service centres, that accurately measure and digitally capture safety-critical tyre condition data, used to reduce operating costs, improve safety and provide audit records for regulatory compliance. Key customers include Bridgestone, Goodyear, Continental and Prometeon (Pirelli), and leading independent providers of vehicle fleet maintenance management software.

 

Transense earns residual royalty income from iTrack - a tyre monitoring system for off-highway vehicles that was designed, developed and supplied by Translogik and sold under subscription to leading global mining companies. The associated sales, support and development infrastructure were sold to Bridgestone Corporation Japan, the world's largest tyre producer, in June 2020, and the intellectual property was licenced exclusively to Bridgestone under a ten-year deal expiring in 2030.

 

For further information please contact transense@walbrookpr.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRDZGFRRMMGFZG
Date   Source Headline
27th Nov 20245:18 pmRNSResult of AGM
27th Nov 20247:00 amRNSAGM Statement and Trading Update
20th Nov 20243:22 pmRNSHolding(s) in Company
30th Oct 20245:27 pmRNSDirector/PDMR Shareholding - acquisition of shares
21st Oct 20247:00 amRNSPosting of Annual Report & Notice of AGM
10th Oct 202411:05 amRNSDirector/PDMR Shareholding - acquisition of shares
27th Sep 202411:28 amRNSHolding(s) in Company
26th Sep 202410:42 amRNSHolding(s) in Company
23rd Sep 20247:00 amRNSFinal Results & Investor Presentation
18th Sep 20247:00 amRNSTransense Selected for £11 Million EV R&D Project
3rd Sep 20247:00 amRNSNotice of Annual Results & Investor Presentation
1st Aug 202410:35 amRNSDirector/PDMR shareholding – acquisition of shares
17th Jul 20247:00 amRNSGrant of Share Options
16th Jul 20247:00 amRNSTrading Update
26th Jun 20247:00 amRNSAppointment of Independent Non-Executive Director
18th Jun 20247:00 amRNSDirector/PDMR Shareholding – acquisition of shares
30th May 20245:25 pmRNSHolding(s) in Company
30th May 20245:20 pmRNSHolding(s) in Company
24th May 20247:00 amRNSHolding(s) in Company
13th May 20247:00 amRNSUpcoming Investor & Analyst Events
10th May 20244:50 pmRNSHolding(s) in Company
1st May 20247:00 amRNSDirector/PDMR - Acquisition of Shares
30th Apr 20245:00 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSTRT joins £37.8m LANDOne project with Airbus & ATI
17th Apr 20246:00 pmRNSTransaction in Own Shares & TVR
15th Apr 20242:51 pmRNSTransaction in Own Shares & TVR
28th Mar 20245:00 pmRNSTotal Voting Rights
25th Mar 20243:35 pmRNSTransaction in Own Shares & TVR
20th Mar 20249:10 amRNSRyan Maughan appointed as Managing Director
29th Feb 20245:00 pmRNSTotal Voting Rights
21st Feb 20242:40 pmRNSHolding(s) in Company
19th Feb 20247:00 amRNSInterim Results & Investor Presentation
15th Feb 20247:00 amRNSHolding(s) in Company
2nd Feb 20245:41 pmRNSTransaction in Own Shares & TVR
31st Jan 20245:00 pmRNSTotal Voting Rights
12th Jan 20247:00 amRNSDirector/PDMR Shareholding
11th Jan 20249:52 amRNSTransaction in Own Shares & TVR
8th Jan 20247:00 amRNSTranslogik Update – Appointment of Sales Director
1st Dec 20237:00 amRNSGrant of share options to Director and employee
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 202311:11 amRNSDirector/PDMR Shareholding
29th Nov 20233:01 pmRNSDirector/PDMR Shareholding
29th Nov 202310:45 amRNSResult of AGM
29th Nov 20237:00 amRNSAGM Statement & Trading Update
24th Nov 20231:11 pmRNSHolding(s) in Company
9th Nov 202312:12 pmRNSDirector/PDMR Shareholding
6th Nov 20234:48 pmRNSTransaction in Own Shares & TVR
25th Oct 202310:00 amRNSPosting of Annual Report & Notice of AGM
16th Oct 20233:23 pmRNSHolding(s) in Company
3rd Oct 20236:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.